Donor pretreatment of grafts from marginal donors improves long-term graft outcome.
Reutzel-Selke
A
A
Department of Surgery, Charité-Virchow Clinic, Charité, Germany.
Tullius
S G
SG
Zschockelt
T
T
Nieminen-Kelhä
M
M
Bachmann
U
U
Jonas
S
S
Pratschke
J
J
Schmidbauer
G
G
Bechstein
W O
WO
Volk
H
H
Neuhaus
P
P
D000818:Animals; D000068338:Everolimus; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects* / Q000502:physiology; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D051381:Rats; D011916:Rats, Inbred F344; D011917:Rats, Inbred Lew; D012307:Risk Factors; D020123:Sirolimus / Q000031:analogs & derivatives / Q000494:pharmacology; D016559:Tacrolimus / Q000494:pharmacology; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D000068338:Everolimus; D011239:Prednisolone; D009173:Mycophenolic Acid; D020123:Sirolimus; D016559:Tacrolimus